Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history

Anna Golebiewska; Anais Oudin; Virginie Baus; Ann-Christin Hau; Eliane Klein; Anne Steino; Jeffrey A. Bacha; Simone P. Niclou; Dennis M. Brown

doi:10.1158/1538-7445.AM2020-5231

Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history

Anna Golebiewska, Anais Oudin, Virginie Baus, Ann-Christin Hau, Eliane Klein, Anne Steino, Jeffrey A. Bacha, Simone P. Niclou, Dennis M. Brown

Research output: Contribution to conference › Abstract › peer-review

Original language	English
DOIs	https://doi.org/10.1158/1538-7445.AM2020-5231
Publication status	Published - Aug 2020
Event	Annual Meeting of the American Association for Cancer Research (AACR) 2020 - Philadelphia, United States Duration: 22 Jun 2020 → 24 Jun 2020

Conference

Conference	Annual Meeting of the American Association for Cancer Research (AACR) 2020
Country/Territory	United States
City	Philadelphia
Period	22/06/20 → 24/06/20

Access to Document

10.1158/1538-7445.AM2020-5231Licence: Unspecified

Cite this

Golebiewska, A., Oudin, A., Baus, V., Hau, A-C., Klein, E., Steino, A., Bacha, J. A., Niclou, S. P., & Brown, D. M. (2020). Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history. Abstract from Annual Meeting of the American Association for Cancer Research (AACR) 2020, Philadelphia, United States. https://doi.org/10.1158/1538-7445.AM2020-5231

@conference{861b615bcb774c889533501350e3b153,

title = "Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history",

author = "Anna Golebiewska and Anais Oudin and Virginie Baus and Ann-Christin Hau and Eliane Klein and Anne Steino and Bacha, {Jeffrey A.} and Niclou, {Simone P.} and Brown, {Dennis M.}",

note = "Cancer Research Volume: 80 Issue number: Suppl.16 Pages (from-to): Article number: 5231 ; Annual Meeting of the American Association for Cancer Research (AACR) 2020 ; Conference date: 22-06-2020 Through 24-06-2020",

year = "2020",

month = aug,

doi = "10.1158/1538-7445.AM2020-5231",

language = "English",

}

Golebiewska, A, Oudin, A, Baus, V , Hau, A-C, Klein, E, Steino, A, Bacha, JA, Niclou, SP & Brown, DM 2020, 'Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history', Annual Meeting of the American Association for Cancer Research (AACR) 2020, Philadelphia, United States, 22/06/20 - 24/06/20. https://doi.org/10.1158/1538-7445.AM2020-5231

Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history. / Golebiewska, Anna; Oudin, Anais; Baus, Virginie et al.
2020. Abstract from Annual Meeting of the American Association for Cancer Research (AACR) 2020, Philadelphia, United States.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Dianhydrogalactitol (VAL-083) exhibits strong efficacy in GBM tumors with different (epi)genetic background and treatment history

AU - Golebiewska, Anna

AU - Oudin, Anais

AU - Baus, Virginie

AU - Hau, Ann-Christin

AU - Klein, Eliane

AU - Steino, Anne

AU - Bacha, Jeffrey A.

AU - Niclou, Simone P.

AU - Brown, Dennis M.

N1 - Cancer Research Volume: 80 Issue number: Suppl.16 Pages (from-to): Article number: 5231

PY - 2020/8

Y1 - 2020/8

U2 - 10.1158/1538-7445.AM2020-5231

DO - 10.1158/1538-7445.AM2020-5231

M3 - Abstract

T2 - Annual Meeting of the American Association for Cancer Research (AACR) 2020

Y2 - 22 June 2020 through 24 June 2020

ER -